The SAM electrophysiology market is expected to grow from US$ 501.31 million in 2022 to US$ 853.82 million by 2028; it is estimated to grow at a CAGR of 9.3% from 2022 to 2028.
The geriatric population is prone to various ailments, such as abdominal discomfort and cardiovascular disease. The growing aging population base and the increasing prevalence of cardiac arrhythmia are a few of the major factors driving the electrophysiology market growth. Electrophysiological devices are used to diagnose these disorders in the geriatric population. According to the World Health Organization (WHO), the geriatric population worldwide will grow from ~1 billion in 2019 to ~2.1 billion by 2050. Therefore, market players are developing effective products to cater to the growing patient population that will benefit the electrophysiology market growth.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM electrophysiology market at a substantial CAGR during the forecast period.
SAM Electrophysiology Market Revenue and Forecast to 2028 (US$ Million)
SAM Electrophysiology Market Segmentation
The SAM electrophysiology market is segmented based on product, indication, and country. Based on product, the market is segmented into electrophysiology ablation catheters, electrophysiology laboratory devices, electrophysiology diagnostic catheters, access devices, and others. The electrophysiology laboratory devices segment dominated the market in 2022 and electrophysiology ablation catheters segment is expected to be fastest growing during forecast period. Based on indication, the market is segmented into atrial fibrillation (AF), atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), wolff-parkinson-white syndrome (WPW), and others. The atrial fibrillation (AF) segment dominated the market in 2022 and is expected to be fastest growing during forecast period. Based on country, the SAM electrophysiology market is segmented into Brazil, Argentina, and the Rest of SAM.
Abbott; Biotronik, Inc.; Boston Scientific Corporation; CardioFocus; GE Healthcare; Johnson & Johnson Services, Inc.; Koninklijke Philips N.V.; Medtronic; MicroPort Scientific Corporation; and Siemens Healthineers AG are among the leading companies operating in the SAM electrophysiology market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 501.31 Million |
| Market Size by 2028 | US$ 853.82 Million |
| CAGR (2022 - 2028) | 9.3% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South America Electrophysiology Market is valued at US$ 501.31 Million in 2022, it is projected to reach US$ 853.82 Million by 2028.
As per our report South America Electrophysiology Market, the market size is valued at US$ 501.31 Million in 2022, projecting it to reach US$ 853.82 Million by 2028. This translates to a CAGR of approximately 9.3% during the forecast period.
The South America Electrophysiology Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Electrophysiology Market report:
The South America Electrophysiology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South America Electrophysiology Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South America Electrophysiology Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)